The phase 2 CELLVX-230 trial is assessing the potential of FK-PC101 to prevent prostate cancer recurrence and delay ...

As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

HIV damages your immune system by targeting CD4 cells. The virus grabs ... of becoming very ill if they don’t start HIV treatment. Anyone who is HIV-positive should take antiretroviral ...

Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some HIV-positive individuals ... relatively stable CD4 + T cell counts over ...

Xenetic (XBIO) Biosciences announced the presentation of positive preclinical data ... data suggests that DNase I impedes neutrophil tumor infiltration, promotes CD4 and CD8 T cell infiltration, and ...

The development of CAR-T cell therapy marks a major breakthrough in cancer treatment. These “living drugs” are T-cells genetically engineered to spread through the body, identify, and destroy cancer ...

CD4 T cells work by triggering an immune response when faced with ... Similarly, research has shown that a low CD4/CD8 count in babies born to HIV-positive mothers can be used to predict whether that ...

What Is a CD4 Count? The CD4 test is one of the more familiar testing assays known to people with HIV. The test measures the level of CD4 helper T-cells in the blood—cells that are not only vital to ...